Research & development increased 82.9%
Research & development changed +82.9% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$102,888→$188,1343 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →AMST financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income decreased 19.4%
Operating income changed -19.4% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
-$662,124→-$790,3763 prior comparisons
Operating margin moved 42335 bp lower
Operating margin changed -42335 basis points from the comparable as-filed period.
-702.18%→-1125.52%3 prior comparisons
Operating cash flow decreased 12.2%
Operating cash flow changed -12.2% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
-$415,765→-$466,5293 prior comparisons
SBC / revenue moved 4810 bp higher
SBC / revenue changed +4810 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
76.62%→124.72%3 prior comparisons
Shares outstanding increased 43.2%
Shares outstanding changed +43.2% from the comparable as-filed period. The change ranks at the 50th percentile of 6 prior comparable changes.
4,572,713→6,549,8516 prior comparisons
Revenue decreased 25.5%
Revenue changed -25.5% from the comparable as-filed period.
$94,296→$70,2233 prior comparisons
Receivables / revenue moved 921 bp higher
Receivables / revenue changed +921 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
10.97%→20.18%3 prior comparisons
Trade receivables increased 37.0%
Trade receivables changed +37.0% from the comparable as-filed period.
$10,344→$14,1723 prior comparisons
R&D / revenue moved 15880 bp higher
R&D / revenue changed +15880 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
109.11%→267.91%2 prior comparisons
Stock-based compensation increased 21.2%
Stock-based compensation changed +21.2% from the comparable as-filed period.
$72,252→$87,5823 prior comparisons
Operating cash-flow margin moved 22344 bp lower
Operating cash-flow margin changed -22344 basis points from the comparable as-filed period.
-440.91%→-664.35%3 prior comparisons
Cash & equivalents decreased 6.9%
Cash & equivalents changed -6.9% from the comparable as-filed period.
$1.8M→$1.7M3 prior comparisons
Current liabilities increased 10.4%
Current liabilities changed +10.4% from the comparable as-filed period.
$427,637→$472,3203 prior comparisons
Total assets decreased 6.0%
Total assets changed -6.0% from the comparable as-filed period.
$2.6M→$2.4M3 prior comparisons
Working capital decreased 7.1%
Working capital changed -7.1% from the comparable as-filed period.
$1.5M→$1.4M3 prior comparisons
Current assets decreased 3.2%
Current assets changed -3.2% from the comparable as-filed period.
$1.9M→$1.8M3 prior comparisons
Working capital / assets moved 65 bp lower
Working capital / assets changed -65 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
56.93%→56.29%3 prior comparisons
Current ratio decreased 12.3%
Current ratio changed -12.3% from the comparable as-filed period.
4.46→3.913 prior comparisons
Operating cash flow increased 33.7%
Operating cash flow changed +33.7% from the comparable as-filed period.
-$677,093→-$449,1581 prior comparisons
Cash & equivalents decreased 77.6%
Cash & equivalents changed -77.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$2.9M→$640,7112 prior comparisons
Operating margin moved 141997 bp higher
Operating margin changed +141997 basis points from the comparable as-filed period.
-2240.87%→-820.90%1 prior comparisons
Revenue increased 171.5%
Revenue changed +171.5% from the comparable as-filed period.
$30,690→$83,3321 prior comparisons
Working capital decreased 78.4%
Working capital changed -78.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$2.9M→$631,9972 prior comparisons
Total assets decreased 60.8%
Total assets changed -60.8% from the comparable as-filed period.
$3.8M→$1.5M2 prior comparisons
Current assets decreased 73.8%
Current assets changed -73.8% from the comparable as-filed period.
$3.1M→$821,9792 prior comparisons
Shares outstanding increased 28.0%
Shares outstanding changed +28.0% from the comparable as-filed period. The change ranks at the 20th percentile of 5 prior comparable changes.
4,572,713→5,852,9855 prior comparisons
Trade receivables increased 327.4%
Trade receivables changed +327.4% from the comparable as-filed period.
$4,440→$18,9751 prior comparisons
Research & development decreased 22.0%
Research & development changed -22.0% from the comparable as-filed period.
$172,098→$134,1921 prior comparisons
Current ratio decreased 70.9%
Current ratio changed -70.9% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
14.88→4.332 prior comparisons
Working capital / assets moved 3452 bp lower
Working capital / assets changed -3452 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
76.87%→42.35%2 prior comparisons
Receivables / revenue moved 830 bp higher
Receivables / revenue changed +830 basis points from the comparable as-filed period.
14.47%→22.77%1 prior comparisons
Operating cash-flow margin moved 166724 bp higher
Operating cash-flow margin changed +166724 basis points from the comparable as-filed period.
-2206.23%→-539.00%1 prior comparisons
R&D / revenue moved 39973 bp lower
R&D / revenue changed -39973 basis points from the comparable as-filed period.
560.76%→161.03%0 prior comparisons
Current liabilities decreased 9.9%
Current liabilities changed -9.9% from the comparable as-filed period.
$210,954→$189,9822 prior comparisons
Operating income increased 0.5%
Operating income changed +0.5% from the comparable as-filed period.
-$687,722→-$684,0721 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.